Page last updated: 2024-09-02

fingolimod hydrochloride and methylprednisolone

fingolimod hydrochloride has been researched along with methylprednisolone in 10 studies

Compound Research Comparison

Studies (fingolimod hydrochloride)	Trials (fingolimod hydrochloride)	Recent Studies (post-2010) (fingolimod hydrochloride)	Studies (methylprednisolone)	Trials (methylprednisolone)	Recent Studies (post-2010) (methylprednisolone)
2,771	157	2,062	20,247	2,602	5,317

Protein Interaction Comparison

Protein	Taxonomy	methylprednisolone (IC50)
Glucocorticoid receptor	Homo sapiens (human)	0.011
Glycine receptor subunit alpha-1	Rattus norvegicus (Norway rat)	0.011
Glycine receptor subunit beta	Rattus norvegicus (Norway rat)	0.011
Glycine receptor subunit alpha-2	Rattus norvegicus (Norway rat)	0.011
Glycine receptor subunit alpha-3	Rattus norvegicus (Norway rat)	0.011

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (20.00)	29.6817
2010's	6 (60.00)	24.3611
2020's	2 (20.00)	2.80

Authors

Authors	Studies
Fujimura, A; Hirata, D; Iwamoto, M; Kamimura, T; Kano, S; Kobayashi, E; Masuyama, J; Minota, S; Okazaki, H; Sato, H; Yoshio, T	1
Giese, T; Meuer, S; Morath, C; Sommerer, C; Zeier, M	1
Havla, J; Hohlfeld, R; Kümpfel, T	1
Baumgartner, A; Gross, CM; Rauer, S; Stich, O	1
Berenguer-Ruiz, L; Feliu-Rey, E; Sempere, AP	1
Accoto, S; De Blasi, V; De Donno, A; De Masi, R; Idolo, A; Orlando, S; Pasca, S; Scarpello, R; Spagnolo, L	1
Andreadou, E; Evangelopoulos, DS; Evangelopoulos, ME; Kilidireas, C; Koutoulidis, V	1
Maeda, Y; Miyazaki, T; Motomura, M; Nakajima, H; Shiraishi, H; Tanaka, K; Tsujino, A	1
Mukharesh, L; Rothstein, TL	1
Alcalá Vicente, C; Bastida Paz, G; Ladrón Abia, P; Martínez Delgado, S	1

Reviews

1 review(s) available for fingolimod hydrochloride and methylprednisolone

Article	Year
[2012: Update on diagnosis and treatment of multiple sclerosis]. Deutsche medizinische Wochenschrift (1946), 2012, Volume: 137, Issue:17 Topics: Administration, Oral; Antibodies, Monoclonal, Humanized; Brain; Combined Modality Therapy; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Administration Schedule; Fingolimod Hydrochloride; Glatiramer Acetate; Glucocorticoids; Humans; Immunosuppressive Agents; Infusions, Intravenous; Interferon-beta; Methylprednisolone; Mitoxantrone; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Natalizumab; Peptides; Plasmapheresis; Propylene Glycols; Pulse Therapy, Drug; Sphingosine; Spinal Cord	2012

Article

Year

[2012: Update on diagnosis and treatment of multiple sclerosis].

Deutsche medizinische Wochenschrift (1946), 2012, Volume: 137, Issue:17

Topics: Administration, Oral; Antibodies, Monoclonal, Humanized; Brain; Combined Modality Therapy; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Administration Schedule; Fingolimod Hydrochloride; Glatiramer Acetate; Glucocorticoids; Humans; Immunosuppressive Agents; Infusions, Intravenous; Interferon-beta; Methylprednisolone; Mitoxantrone; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Natalizumab; Peptides; Plasmapheresis; Propylene Glycols; Pulse Therapy, Drug; Sphingosine; Spinal Cord

2012

Other Studies

9 other study(ies) available for fingolimod hydrochloride and methylprednisolone

Article	Year
Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus. The Journal of rheumatology, 2002, Volume: 29, Issue:4 Topics: Administration, Oral; Animals; Antibodies, Antinuclear; Antigen-Antibody Complex; Apoptosis; Bone Marrow Cells; Cells, Cultured; Disease Models, Animal; DNA; Female; Fingolimod Hydrochloride; Flow Cytometry; Immunoglobulin G; Immunosuppressive Agents; Interleukin-2; Kidney Glomerulus; Longevity; Lupus Erythematosus, Systemic; Lymphoid Tissue; Methylprednisolone; Mice; Mice, Inbred BALB C; Mice, Inbred MRL lpr; Propylene Glycols; Sphingosine; T-Lymphocytes	2002
Activity of nuclear factor of activated T cells is independent of the number of peripheral lymphocytes in FTY720-treated patients. Transplantation proceedings, 2008, Volume: 40, Issue:5 Topics: Cyclosporine; Fingolimod Hydrochloride; Gene Expression Regulation; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-2; Kidney Transplantation; Lymphocyte Activation; Lymphopenia; Methylprednisolone; NFATC Transcription Factors; Propylene Glycols; RNA, Messenger; Sphingosine; T-Lymphocytes	2008
Multiple sclerosis rebound following herpes zoster infection and suspension of fingolimod. Neurology, 2012, Nov-06, Volume: 79, Issue:19 Topics: Adult; Anti-Inflammatory Agents; Brain; Fingolimod Hydrochloride; Herpes Zoster; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Propylene Glycols; Sphingosine	2012
Rebound of disease activity during pregnancy after withdrawal of fingolimod. European journal of neurology, 2013, Volume: 20, Issue:8 Topics: Adult; Anti-Inflammatory Agents; Disability Evaluation; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Methylprednisolone; Multiple Sclerosis, Relapsing-Remitting; Pregnancy; Pregnancy Complications; Propylene Glycols; Sphingosine	2013
Dramatic recovery of steroid-refractory relapsed multiple sclerosis following Fingolimod discontinuation using selective immune adsorption. BMC neurology, 2015, Jul-31, Volume: 15 Topics: Adsorption; Adult; Autoantibodies; Female; Fingolimod Hydrochloride; Humans; Immunoglobulin G; Immunologic Factors; Lymphopenia; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Myelin Sheath; Natalizumab; Plasma Exchange; Steroids; Treatment Outcome	2015
Pulsed corticosteroid treatment in MS patients stabilizes disease activity following natalizumab withdrawal prior to switching to fingolimod. The International journal of neuroscience, 2016, Volume: 126, Issue:12 Topics: Adrenal Cortex Hormones; Adult; Cohort Studies; Disability Evaluation; Female; Fingolimod Hydrochloride; Humans; Immunologic Factors; JC Virus; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Natalizumab; Time Factors	2016
A case of recurrent optic neuritis associated with cerebral and spinal cord lesions and autoantibodies against myelin oligodendrocyte glycoprotein relapsed after fingolimod therapy. Rinsho shinkeigaku = Clinical neurology, 2016, 04-28, Volume: 56, Issue:4 Topics: Adolescent; Autoantibodies; Brain; Female; Fingolimod Hydrochloride; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Methylprednisolone; Myelin-Oligodendrocyte Glycoprotein; Myelitis; Optic Neuritis; Recurrence; Spinal Cord	2016
Fingolimod-induced immune thrombocytopenic purpura (ITP). Clinical neurology and neurosurgery, 2020, Volume: 197 Topics: Adult; Fingolimod Hydrochloride; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Methylprednisolone; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Purpura, Thrombocytopenic, Idiopathic; Sphingosine 1 Phosphate Receptor Modulators; Treatment Outcome	2020
Fingolimod-induced remission in a patient with ulcerative colitis and multiple sclerosis. Gastroenterologia y hepatologia, 2021, Volume: 44, Issue:2 Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Colitis, Ulcerative; Drug Therapy, Combination; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; JC Virus; Leukapheresis; Leukoencephalopathy, Progressive Multifocal; Methylprednisolone; Middle Aged; Multiple Sclerosis; Remission Induction; Sphingosine-1-Phosphate Receptors; Tumor Necrosis Factor-alpha; Virus Activation	2021